Sensome, formerly Instent, a Paris, France-based company developing a micro-sensor technology for smart medical devices out of France’s Ecole polytechnique, completed a €4.7m seed funding round.
The round was led by Kurma Diagnostics with participation from Paris-Saclay Seed Fund and ID Invest, as well as a group of business angels.
The company intends to use the funds to bring its first product to clinical trials.
Co-founded by Franz Bozsak, CEO, and Abdul Barakat, professor at the Hydrodynamics Laboratory at Ecole polytechnique, Sensome provides novel sensing technology that can be integrated with any medical device to identify biological tissues in contact with the device. The technology combines micrometric impedance sensors that communicate wirelessly outside the body and machine learning algorithms for accurate and predictive real-time analysis.
The company’s first product integrates its proprietary technology with a guidewire for the treatment of ischemic stroke.